Anti-ischemic medicament
US5512572A · kind A · utility
6Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 1994 |
| Grant date | Apr 30, 1996 |
| Priority date | — |
| Expiry date | Nov 22, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for preventing or treating myocardial ischemia in a mammalian organism is disclosed. The compound 4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl!hydrazono!prop anedinitrile or its enantiomer or a pharmaceutically acceptable salt there is administered to a mammalian organism in need of such prevention or treatment. The compound may be administered in its racemic form or in a form which is substantially free of the (+)-enantiomer or substantially free of the (-)-enantiomer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.